To investigate the clinical relevance of the IFN-I → KDM1B axis, we first calculated the correlation between KDM1B, IFN-I-related metagenes, stem-related reprogramming factors, IFN-I signatures and stemness signatures using publicly available transcriptomic data on BC patients responsive to anthracyclines11,30. Here, KDM1B is linked to breast cancer.